Alkermes Investigational Site

Decatur, Georgia 30030

1 studies enrolling now · 11 studies all time

What they study most

Alcohol Use Disorder, Bipolar I Disorder, Major Depressive Disorder, Refractory Major Depressive Disorder, Schizophrenia, Schizophreniform Disorder

Studies at this site

• Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects — Enrolling by invitation
• Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 — Completed
• Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I Disorder — Completed
• A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder — Completed
• A Study of ALKS 3831 in Adults With Schizophrenia — Completed
• A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia — Completed
• A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD) — Stopped early
• A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD) — Completed
• A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study) — Completed
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study — Completed
• A Long-Term Safety Study of ALKS 5461 — Completed